Ligand Pharmaceuticals LGND Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's interest income?
- Ligand Pharmaceuticals (LGND) reported interest income of $6.66M in Q1 2026.
- How has Ligand Pharmaceuticals's interest income changed year-over-year?
- Ligand Pharmaceuticals's interest income increased by 275.8% year-over-year, from $1.77M to $6.66M.
- What is the long-term trend for Ligand Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's interest income has grown at a 98.2% compound annual growth rate (CAGR), from $886K to $13.66M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.